Cooperative Agreement U01EB037534
- This federal Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of an innovative magnetic resonance imaging (MRI) technology. The $391,875 award to The General Hospital Corporation, doing business as Massachusetts General Hospital, aims to address the flip angle inhomogeneity issue in high-field 7...
- This federal Project Grant award for $641,360 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) aims to develop a digitally programmable and versatile radio frequency (RF) coil for ultra-high-field brain magnetic resonance imaging (MRI) at 7 Tesla. The award will support the creation of an "Any-Nucleus Distributed Active Programmable Transmit...
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- This $481,250 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports the development of an innovative RF coil array for magnetic resonance-guided focused ultrasound (MRGFUS) neuromodulation. The objective is to create a specialized RF coil that can improve signal-to-noise ratio and image quality for MRGFUS, which is a non-invasive...
- The U.S. National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,758,475 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop next-generation in-vivo diffusion MRI (dMRI) technologies. This funding will enable MGH to create novel acquisition methods that can provide significant...
- This Cooperative Agreement award, valued at $700,067.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) federal grant program. The primary goal of this project is to develop and validate a new magnetic resonance-based multimodal imaging technology that can simultaneously acquire a large set of molecular and tissue property biomarkers...
- This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) will provide $600,000 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a next-generation 3 Tesla human MRI scanner for mental health research. The new MRI system will replace an obsolete 16-year-old scanner and integrate with MGH's existing PET-MRI facility at the Athinoula A. Martinos Center for Biomedical Imaging. The...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $514,357 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the Massachusetts Institute of Technology (MIT) on June 1, 2025. The purpose of this grant is to support the development and prototype demonstration of a portable, liquid-helium-free 1-T/560-mm RT bore point-of-care MRI magnet. This innovative MRI technology is intended to...
- This National Science Foundation (NSF) Cooperative Agreement award, funded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, focuses on the commercialization of a novel magnetic resonance imaging (MRI) platform. The $1,186,778 project aims to develop an affordable, compact, and silent head-only MRI scanner that can provide high-quality brain imaging at one-tenth the cost and footprint of traditional MRI systems. The innovative "B1 encoding" system...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has awarded a $306,203 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Resonance Research Inc. The grant, awarded on September 1, 2024, supports the development of an advanced, digitally-controlled multiband shimming system for improved neuroimaging using high-field magnetic resonance imaging (MRI) scanners. The goal is to create a...
This Cooperative Agreement award from the National Institute of Biomedical Imaging and Bioengineering (CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health) provides $808,070 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a novel head-neck imaging system for comprehensive neurological MRI exams at 7 Tesla. The project aims to create a 16-channel transmit/64-channel receive radiofrequency coil with extended anatomical coverage down to the C6 vertebra, enabling full head-neck imaging at ultra-high field 7T MRI. The researchers will apply advanced techniques to optimize RF and B0 field homogeneity across the expanded field-of-view, overcoming limitations of standard head coils. This system is expected to significantly improve the diagnosis and tracking of central nervous system diseases involving lower brain regions, brainstem, and cervical spine, by providing enhanced resolution and soft tissue contrast compared to conventional 3T MRI.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $808.1k | 7/31/25 |